Table 7.
Types of Non-narcotics Administered During Emergency Department Encounter and Prescribed at Discharge: 2017–2018 vs 2013–2014
| Time | Non-narcotic | n (%) |
Estimated ORa | 95% CI | p-Value | |
|---|---|---|---|---|---|---|
| Among encounters with at least one non-narcotic prescribed | ||||||
| 9/1/2017 to 8/31/2018 | 9/1/2013 to 8/31/2014 | |||||
| During ED encounter | Ketorolac | 125 (81) | 217 (85) | 0.76 | 0.45–1.27 | 0.296 |
| Lidocaine | 21 (14) | 71 (28 | 0.41 | 0.24–0.7 | 0.001 | |
| Haloperidol | 2 (1) | 1 (<1 | — | — | — | |
| Other | 29 (19) | 13 (5) | 4.25 | 2.12–8.53 | <0.001 | |
| At discharge | Ketorolac | 3 (3) | 6 (5) | — | — | — |
| Lidocaine | 1 (1) | 0 (0) | — | — | — | |
| Haloperidol | 0 (0) | 0 (0) | — | — | — | |
| Other | 90 (96 | 121 (95) | 1.25 | 0.32–4.89 | 0.749 | |
a
OR for (9/1/2017 to 8/31/2018) vs (9/1/2013 to 8/31/2014).